Description - Side Effects of Drugs Annual by Jeffrey K. Aronson
The Side Effects of Drugs Annual is designed to provide a critical and up-to-date account of new information related to adverse drug reactions and interactions from the clinician's point of view. Under the supervision of the series editors, an international team of expert authors have gathered together the latest information on adverse drug effects from the international literature. In addition to describing new reports of adverse drug effects, the authors have subjected those reports to critical analysis, setting them into context in terms of clinical relevance and importance, and cross-referring to previous reports where necessary. New adverse effects are reported and evaluated and previously reported adverse effects are re-evaluated in the light of the most recent information. A special feature is the reviews, in which selected adverse effects are discussed in depth. The use of the book is enhanced by two separate indexes, allowing the reader to enter the text by drug name, adverse effect name, or drug interaction. The current Annual is the first update of the standard encyclopaedic work in this field, http://www.elsevier.nl/locate/isbn/0444500936 Meyler's Side Effects of Drugs, Fourteenth Edition, which was published in December 2000.
Buy Side Effects of Drugs Annual by Jeffrey K. Aronson from Australia's Online Independent Bookstore, Boomerang Books.
(234mm x 156mm x 38mm)
Elsevier Science Ltd
Publisher: Elsevier Science & Technology
Country of Publication:
Other Editions - Side Effects of Drugs Annual by Jeffrey K. Aronson
Book Reviews - Side Effects of Drugs Annual by Jeffrey K. Aronson
Author Biography - Jeffrey K. Aronson
Dr Jeffrey K. Aronson is a consultant clinical pharmacologist and physician in the Department of Primary Health Care in the University of Oxford and a consultant physician in the Oxford Radcliffe Hospitals Trust. He has been associated with the Meyler series since 1977 and has published many research papers on adverse drug reactions. He is President of the British Pharmacological Society and serves on many committees concerned with drug therapy, including the Technology Appraisal Committee of the UK's National Institute for Health and Clinical Excellence (NICE) and the Joint Formulary Committees of the British National Formulary and the British National Formulary for Children.